Remote saliva collection for childhood leukemia survivors
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tests whether it is easy and acceptable for childhood leukemia survivors, their siblings, and caregivers to collect saliva samples at home and send them to researchers. It aims to understand how well this remote method works for future research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a survivor of childhood acute lymphocytic leukemia (ALL), treated on a specific St. Jude study (TOTXVI or TOT17).
- You are at least 5 years past diagnosis and 2 years past treatment, and are cancer-free.
- You did not receive cranial radiation as part of your ALL treatment.
- You are between 8 and 18 years old.
- You have completed your After Completion of Therapy (ACT) clinic consultation.
- You can speak and read English, and have internet access.
- If you are a sibling or caregiver: you are aged 8–18 (sibling) or live full-time with the survivor (caregiver), and meet the language and internet requirements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a remote, at-home approach can identify problems with the autonomic nervous system (the part that controls heart rate, blood pressure, and digestion) in adult survivors of childhood leukemia or lymphoma. If you join, you will complete a set of simple tasks (the Ewing battery) from home to see how your body responds.
This study collects stored samples (like blood or tissue) and health information from people affected by cancer at a young age, including some survivors. The goal is to build a library of specimens and data that researchers can use to better understand childhood and young adult cancers.
This trial looks at blood and bone marrow samples from children and teens whose leukemia has come back or is hard to treat. The goal is to better understand the disease and guide future options for these patients.
This study looks at leukemia “genetic clues” using special stored samples, including cord blood saved at birth. It may help researchers better understand leukemia biology and how common mutations may show up early.
This study gathers key health information at the start of treatment for children and teens newly diagnosed with certain types of leukemia or lymphoma. The goal is to find the best way to begin therapy right away, without waiting for extra tests.
This study tests a support program that helps parents give their child's daily leukemia medicine (6-MP) on schedule and overcome any barriers. It aims to make it easier for families to stick with treatment.
Hear when a new Survivors of Childhood Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.